After a manufacturing problem irked the FDA and scared off partner GlaxoSmithKline, Impax Laboratories is resubmitting its investigational drug for Parkinson’s disease, hoping it can clear an agency inspection and finally get its treatment on the market.

…read more

Source: Impax gives it another go with a once-rejected Parkinson’s drug


0 No comments